rs118204046
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_015702.3(MMADHC):c.746A>G(p.Tyr249Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000378 in 1,613,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000038 ( 0 hom. )
Consequence
MMADHC
NM_015702.3 missense
NM_015702.3 missense
Scores
11
7
1
Clinical Significance
Conservation
PhyloP100: 4.03
Genes affected
MMADHC (HGNC:25221): (metabolism of cobalamin associated D) This gene encodes a mitochondrial protein that is involved in an early step of vitamin B12 metabolism. Vitamin B12 (cobalamin) is essential for normal development and survival in humans. Mutations in this gene cause methylmalonic aciduria and homocystinuria type cblD (MMADHC), a disorder of cobalamin metabolism that is characterized by decreased levels of the coenzymes adenosylcobalamin and methylcobalamin. Pseudogenes have been identified on chromosomes 11 and X.[provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.809
PP5
Variant 2-149570119-T-C is Pathogenic according to our data. Variant chr2-149570119-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 763.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-149570119-T-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMADHC | NM_015702.3 | c.746A>G | p.Tyr249Cys | missense_variant | 8/8 | ENST00000303319.10 | NP_056517.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMADHC | ENST00000303319.10 | c.746A>G | p.Tyr249Cys | missense_variant | 8/8 | 1 | NM_015702.3 | ENSP00000301920.5 | ||
MMADHC | ENST00000422782.2 | c.848A>G | p.Tyr283Cys | missense_variant | 9/9 | 5 | ENSP00000408331.2 | |||
MMADHC | ENST00000428879.5 | c.746A>G | p.Tyr249Cys | missense_variant | 7/7 | 2 | ENSP00000389060.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
5
AN:
152198
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251290Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135848
GnomAD3 exomes
AF:
AC:
18
AN:
251290
Hom.:
AF XY:
AC XY:
11
AN XY:
135848
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461616Hom.: 0 Cov.: 31 AF XY: 0.0000536 AC XY: 39AN XY: 727106
GnomAD4 exome
AF:
AC:
56
AN:
1461616
Hom.:
Cov.:
31
AF XY:
AC XY:
39
AN XY:
727106
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74348
GnomAD4 genome
AF:
AC:
5
AN:
152198
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Methylmalonic aciduria and homocystinuria type cblD Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Mar 25, 2022 | The MMADHC c.746A>G variant is classified as Pathogenic (PS4_Moderate, PS3, PM2, PM3, PP3) The MMADHC c.746A>G variant is a single nucleotide change in exon 8/8 of the MMADHC gene, which is predicted to change the amino acid tyrosine at position 249 in the protein to cysteine. The variant has been reported in probands with a clinical presentation of OMIM:277410 ( Detected in at least 4 affected individuals ) (PS4_Moderate). The variant is rare in population databases (PM2). Well-established functional studies show a deleterious effect of this variant (PS3). PubMed: 18385497 - Severely reduced methionine or methylcobalamin synthesis in either cblD-homocystinuria or cblD-combined cells. PMID: 22156578 - Expression studies showed that the c.746A>G;p.(Tyr249Cys) variant was unable to rescue methylcobalamin (MeCbl) synthesi. This variant has been detected in trans with a pathogenic variant c.545C>A;p.(T182N) for this recessive condition (PM3). + 3 homozygous occurrences. Computational predictions support a deleterious effect on the gene or gene product (PP3). The variant has been reported in dbSNP (rs118204046) and in the HGMD database: CM081190. It has been reported as Likely pathogenic by other diagnostic laboratories (ClinVar Variation ID: 763). - Variant detected in an individual with homocystinuria. Variant in trans with c.545C>A;p.(Thr182Asn). - Constructs containing the missense alleles associated with isolated homocystinuria (545C→A, 746A→G, and 776T→C) did not restore methionine or methylcobalamin synthesis in either cblD-homocystinuria or cblD-combined cells, confirming that these mutant alleles cause the homocystinuria phenotype. - |
Pathogenic, criteria provided, single submitter | clinical testing | Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 28, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | May 20, 2023 | The observed missense variant c.746A>G(p.Tyr249Cys) in MMADHC gene has been reported in homozygous and compound heterozygous state in individuals with cobalamin D deficiency (Coelho D, et al., 2008, Stucki M, et al., 2012, Atkinson C, et al., 2014). This mutation occurs in a region of the MMADHC gene that is highly conserved among species. Experimental studies have shown that this variant causes deficient synthesis of methylcobalamin (Coelho D, et al., 2008, Atkinson C, et al., 2014). The c.746A>G variant has 0.01% allele frequency in gnomAD Exomes. This variant has been submitted to the ClinVar database as Uncertain Significance/ Likely Pathogenic/ Pathogenic.The amino acid Tyrosine at position 249 is changed to a Cysteine changing protein sequence and it might alter its composition and physico-chemical properties. Multiple lines of computational evidence (Polyphen, SIFT and MutationTaster) predict a damaging effect on protein structure and function for this variant. The amino acid change p.Tyr249Cys in MMADHC is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Jul 29, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 29, 2023 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 249 of the MMADHC protein (p.Tyr249Cys). This variant is present in population databases (rs118204046, gnomAD 0.04%). This missense change has been observed in individual(s) with cobalamin D deficiency (PMID: 18385497, 22156578, 25155779). ClinVar contains an entry for this variant (Variation ID: 763). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MMADHC protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects MMADHC function (PMID: 18385497, 22156578). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Cobalamin C disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 02, 2022 | Variant summary: MMADHC c.746A>G (p.Tyr249Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.2e-05 in 251290 control chromosomes, predominantly at a frequency of 0.00042 within the South Asian subpopulation in the gnomAD database. This frequency is not significantly higher than expected for a pathogenic variant in MMADHC causing Methylmalonic Acidemia With Homocystinuria (7.2e-05 vs 0.00079), allowing no conclusion about variant significance. c.746A>G has been reported in the literature in multiple individuals affected with Methylmalonic Acidemia With Homocystinuria, including one heterozygote (Coelho_2008) and 3 homozygotes (Stucki_2012, Atkinson_2014). These data indicate that the variant is very likely to be associated with disease. Two publications have reported experimental evidence evaluating an impact on protein function, where the variant protein was found impacting methylcobalamin synthesis (with 10%-<30% of normal activity) but not adenosylcobalamin synthesis (Coelho_2008, Stucki_2012). One ClinVar submitter has assessed this variant since 2014: the variant was classified as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblD TYPE Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 03, 2008 | - - |
See cases Uncertain:1
Uncertain significance, flagged submission | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Mar 22, 2019 | ACMG classification criteria: PM2, PP3, PP5 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D;D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M;.
PrimateAI
Pathogenic
T
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;D
Vest4
MutPred
0.70
.;.;Loss of disorder (P = 0.085);
MVP
MPC
0.27
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at